Articles tagged with Antiinflammatory Drugs
Research found that common anti-inflammatory drugs taken by children can alter the formation of dental enamel, leading to defects. The study's authors suggest potential harm from widespread use of these medications and plan to conduct a clinical trial to confirm findings in humans.
A large international study found that adopting and maintaining a healthy lifestyle may prevent up to 60% of Crohn's disease and ulcerative colitis cases. The study analyzed data from over 300,000 participants and estimated that a low risk score for inflammatory bowel disease could have prevented a significant proportion of cases if an...
Researchers at Tokyo University of Science have developed a unique 3D COF with scu-c topology, exhibiting efficient gas adsorption and drug delivery capabilities. The material has been shown to exhibit excellent hydrogen and methane adsorption properties.
Dr. Matt Budoff will investigate the effects of Colchicine in people with coronary artery disease, comparing it to placebo. The goal is to determine if this anti-inflammatory medication can reduce plaque volume and improve patient outcomes.
Researchers have developed a transport nanoparticle to deliver an anti-inflammatory drug, Necrosulfonamide (NSA), directly into macrophages to combat inflammatory overactivation. The mesoporous silica nanoparticle is fully biodegradable and non-toxic, showing remarkable efficacy in reducing inflammation.
Researchers developed a new machine-learning approach to classify macrophages, which are key immune cells involved in pro- or anti-inflammatory responses. This technology could be used as a diagnosis tool or to highlight the role of specific cell types in disease environments.
Researchers at KAIST developed a novel fusion protein drug, αAβ-Gas6, which efficiently eliminates amyloid beta (Aβ) without causing inflammatory side effects. The study showed that αAβ-Gas6 promoted the robust uptake of Aβ without inflammation and neurotoxicity.
The 2016 CDC guideline aimed to reduce opioid-related overdose deaths by encouraging clinicians to weigh the benefits and risks of prescribing opioids. Researchers found a significant increase in nonopioid pain medication prescribing rates, coinciding with a drop in opioid prescribing.
A study found ranolazine reduces inflammation and atherosclerotic plaques in blood vessels, lowering the risk of heart attack or stroke. The established drug also has an anti-inflammatory effect, reducing chronic vascular inflammation.
Researchers from McGill University and Italy found that blocking neutrophils can prolong pain, even with anti-inflammatory drugs. The study suggests reconsidering acute pain treatment, and findings are supported by a large UK analysis.
Researchers have pinpointed a possible new target for treating patients with juvenile myelomonocytic leukemia (JMML), a highly aggressive blood cancer. Treatment using anti-inflammatories showed promise in rescuing JMML-like symptoms in zebrafish, suggesting a potential new approach to combating the disease.
A new study suggests that supplementing a diet with Ascidiacea, also known as sea squirts, reverses some main signs of aging in animal models. The researchers found that plasmalogens, vital to body processes, decrease with age and contribute to neurodegenerative diseases like Alzheimer's and Parkinson's.
Researchers developed a disposable electrochemical sensor using graphite-based molecularly imprinted polymers to detect theophylline levels. The sensor can identify low concentrations of theophylline (2.5 μg/mL) in whole blood within 3 seconds, enabling real-time monitoring and potential overdose prevention.
Researchers found that NSAID use negates the bone-protective effects of bisphosphonate clodronate on preventing osteoporotic fractures. The study suggests caution in extrapolating these data to more widely used bisphosphonates, as concomitant usage may lead to reduced fracture risk.
Researchers at Charité, MDC, and FU Berlin have studied the mechanisms of action of antibody and dexamethasone treatments for COVID-19. They found that combination therapy is more effective in reducing viral activity and inflammation in lung tissue, suggesting a potential game-changer in treating severe cases.
Researchers found that some painkillers and fever medications may help fight infection, while others can weaken the immune system. The review highlights the need for more studies on the impact of these medicines on infectious diseases.
A recent study led by Dr Simon Fraser from the University of Southampton found that painkiller prescriptions decreased during the pandemic, but high-risk individuals continued to receive them. The research highlights the need for greater caution when prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to prevent kidney damage.
A new longitudinal study found that frequent use of NSAIDs or acetaminophen, as well as regular use of COX-2 inhibitors, is associated with a higher risk of developing chronic persistent tinnitus. Low-dose aspirin use did not elevate risk, but moderate-dose aspirin use was linked to higher risk among women under 60.
Researchers discover novel compound AD732 with anti-inflammatory and analgesic properties, outperforming standard NSAIDs while causing minimal harm. The compound may be a safer alternative for treating pain and inflammation in difficult diseases like ulcerative colitis and Crohn's disease.
Researchers found that geriatric cotton rats given ibuprofen cleared RSV more quickly than those without the drug. Ibuprofen improved immune response by lowering aging-related inflammation, suggesting a potential role for the drug in providing lasting immunity against RSV.
A new case study presents a medially challenging situation where NSAIDs triggered anaphylactic reactions in a female runner. The patient's symptoms worsened with exercise, emphasizing the importance of being aware of this phenomenon and taking preventive measures.
A potential new therapy for urinary tract infections has been discovered using the FDA-approved anti-inflammatory drug dimethyl fumarate, which activates the NRF2 pathway. This balance between eliminating bacteria and minimizing tissue damage is crucial to treating UTIs.
A four-year multicentre study by Ruhr-University Bochum's Department of Dermatosurgery found that adalimumab can be used both before and after surgery for moderate to severe hidradenitis suppurativa. The study involved 200 patients and showed the drug to be effective and safe in this context.
A nationwide study found that US health systems used COVID-19 treatments dexamethasone and remdesivir variably, with dexamethasone possibly underused in severe cases. The use of these drugs peaked in mid-2020 but fell to lower rates by late February 2021.
Researchers found that combining anti-rheumatic drugs can reduce the risk of cardiovascular disease in rheumatoid arthritis patients. Two specific combinations - tumour necrosis factor inhibitors and hydroxychloroquine - showed promise in preserving endothelial function.
A team of MIT chemical engineers has developed a new method for incorporating hydrophobic drugs into tablets or other formulations, which allows for higher drug loading and potentially smaller dosages. This could lead to improved patient compliance and effectiveness, especially for people who have difficulty swallowing pills.
GlycoNet's GlycoCage technology involves 'caging' IBD drugs with carbohydrate molecules to prevent premature uptake in the upper GI tract. This approach aims to increase the efficacy of IBD treatments and reduce systemic side effects, such as those associated with steroid anti-inflammatory drugs.
A recent study analyzing 156,570 hospitalized patients found that anti-infective agents, cancer medications, and nonsteroidal anti-inflammatory drugs were the most toxic to the liver. Voriconazole, an antifungal medication, was associated with the highest incidence of drug-induced liver injury.
A new study found that short-term air pollution exposure can impair cognitive performance, but taking nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin can reduce these effects. The study used data from the Normative Aging Study and found that elevated PM2.5 exposure over 28 days was associated with declines in global cognitiv...
Researchers found that hymecromone, a spasmolytic drug, reduces the production of anti-inflammatory molecules in astrocytes. This could lead to new treatments for neurodegenerative diseases such as Alzheimer's. Hymecromone's mechanism of action is thought to involve reducing hyaluronic acid synthesis, which affects inflammation.
Scientists create magnesium-based micromotors that produce hydrogen bubbles, which propel the motors and release hydrogen gas into inflamed joints. This therapy shows promise in reducing joint pain, swelling, and bone erosion in animal models of rheumatoid arthritis.
A new prediction model has identified 10 preoperative characteristics that may predict persistent high-dose opioid use after knee replacement surgery. Certain patient demographics and medication history, including substance abuse and benzodiazepine use, were found to be risk factors.
Researchers at Scripps Research Institute devised a method to separate beneficial anti-inflammatory properties from unwanted side effects in glucocorticoid drugs. Two new compounds show steroidal anti-inflammatory action with specific traits, including boosting muscle supply and reducing risk of muscle-wasting.
Cartilage cells engineered to respond to mechanical stress can produce an anti-inflammatory drug to reduce joint pain and limit arthritis-related damage. The technology could lead to more effective treatments for osteoarthritis by delivering drugs in response to specific movements or weight-bearing.
Researchers developed a biology-based mathematical model that incorporates information about SARS-CoV-2 and various treatments. The model suggests optimal treatment for older patients and those with pre-existing conditions, including the use of clot-preventing drugs and immune response-modifying drugs.
A new study finds that regular use of acid reflux drugs is associated with a heightened risk of developing type 2 diabetes. The longer these drugs are taken, the greater the risk seems to be, prompting researchers to advise blood glucose check-ups for long-term users.
Researchers at TUM have found that DNA binding is essential for the anti-inflammatory effect of steroids like cortisone. This discovery refutes the common theory that steroids' effects are based on protein-to-protein interaction, and opens up new avenues for developing cortisone alternatives with fewer side effects.
The new guidelines offer additional recommendations for photobiomodulation therapy and benzydamine, as well as a stronger guideline statement for cryotherapy. Researchers also found that natural honey may help prevent mucositis in head and neck cancer patients, although long-term effects are unclear.
The study found that integrated pharmacists in GP teams flagged 786 patients with medication issues, leading to changes and potential cost savings. This collaborative model of care has the potential to alleviate pressures on GP practices and improve patient care.
A recent study estimates that over 237 million medication errors occur annually in England, resulting in significant financial and human costs. The majority of these errors are minor, but some can have serious consequences, such as hospital admissions and deaths.
The study analyzed 600 COVID-19 cases in patients with rheumatic diseases and found no association between immunosuppressant intake and hospitalization. Treatment with high doses of prednisone was associated with a higher risk of hospitalization, while TNF-alpha inhibitors showed reduced hospitalization rates.
Researchers have identified two anti-inflammatory drugs that can inhibit the replication of the COVID-19 virus. The study used computational techniques to analyze 6,466 authorized drugs and predicted that Carprofen and Celecoxib could be effective in inhibiting the main protease enzyme responsible for the virus's replication.
Researchers have uncovered the molecular mechanism of boswellic acid, a substance responsible for frankincense's anti-inflammatory effect. Frankincense reprograms the inflammatory enzyme 5-lipoxygenase into an anti-inflammatory enzyme.
Researchers are launching a clinical trial to evaluate the efficacy and safety of baricitinib in patients with moderate to severe COVID-19. The trial aims to reduce inflammation and slow disease progression, potentially saving lives.
Researchers recommend using cardiovascular anti-inflammatory therapies to treat COVID-19 patients with severe cardiovascular problems, citing potential risks with current treatments. The study provides guidance for clinicians on selecting specific therapies depending on disease severity and patient response.
A team of scientists at Ludwig-Maximilians-Universität München has isolated immune cells from human tonsils obtained following routine surgery, allowing them to analyze the immune response and test anti-inflammatory agents. The new culture system enables researchers to study human lymphoid tissue under physiologically relevant conditions.
A study led by McGill University found that anti-inflammatory medications are most effective when taken during the active periods of our biological clocks, promoting post-operative healing and recovery. This discovery suggests a new approach to treating pain and inflammation following surgery.
Researchers developed a cold-stable spray gel containing heparin and ibuprofen to treat frostbite injuries, showing improved healing rates compared to conventional treatments. The treatment reduced inflammation and accelerated healing, potentially preventing gangrene and amputation.
Researchers found that cromolyn sodium delayed the development of ALS symptoms in mice with a genetic mutation causing the disease. The treatment also protected neurons from degeneration and reduced inflammation by targeting mast cells.
Researchers found that healthy men taking commonly prescribed doses of glucocorticoids for a short period experienced changes in blood sugar metabolism, associated with an increased risk of developing diabetes. The study highlights the need for medical professionals to consider and monitor potential side effects.
A pooled analysis of data from 30 studies found that anti-inflammatory agents were 52% more effective in reducing symptom severity and 79% more effective in eliminating symptoms than placebo. NSAIDs, omega 3 fatty acids, statins, and minocyclines were among the most effective agents.
Researchers developed an injectable drug formulation using lipid nanoparticles to sustain the effect of naproxen in treating temporomandibular joint inflammation. The study showed significant reduction in inflammation and absence of side effects, making it a potential treatment option for this condition.
Research reveals that active pharmaceutical ingredients can persist in groundwater due to sorption potential and biodegradability. Medicines like ofloxacin and naproxen were detected in groundwater samples, with varying levels of risk to human health.
Researchers at the Center for Genomic Regulation discovered a novel way to control inflammation by understanding how cells produce IL-1β, a crucial molecule involved in inflammation. By targeting the unfolded protein response and GRASP55 pathways, they identified potential avenues for developing anti-inflammatory drugs.
Bioactive compounds 5 and others were found to be potent inhibitors of ROS and NO. Most active compounds showed good anti-inflammatory potential without toxicity on NIH-3T3 cells.
New research suggests that taking non-steroidal anti-inflammatory drugs (NSAIDs) for pain can increase the risk of severe Clostridium difficile infections. The study found that brief exposure to an NSAID prior to infection worsened infection severity and shortened survival in mice.
Researchers have created a new drug that targets the colon and limits its exposure, offering hope for treating Familial Adenomatous Polyposis (FAP) and preventing colon cancer. The treatment could be effective in reducing life expectancy by nearly 50% for children with FAP.
Researchers at Washington State University developed a new nanoparticle system that targets infections to release antibiotic and anti-inflammatory agents. This breakthrough technology aims to improve treatment for sepsis and bacterial infections by reducing the spread of bacteria and inflammation.
A preclinical study found that combining soy lecithin with an NSAID increased anticancer properties and reduced gastrointestinal bleeding. The combination provided superior protection against colorectal cancer without the usual side effects, according to researchers at UTHealth.
A WSU research team has made a breakthrough in 3D-printed bone health by combining natural medical cures with modern biomedical devices. The addition of curcumin to ceramic scaffolds improved bone growth capabilities by 30-45%, offering new hope for treating bone diseases like osteoporosis.